Sleep Disruption in Breast Cancer Patients and Survivors

Authors:
Oxana Palesh From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.

Search for other papers by Oxana Palesh in
Current site
Google Scholar
PubMed
Close
 PhD, MPH
,
Arianna Aldridge-Gerry From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.

Search for other papers by Arianna Aldridge-Gerry in
Current site
Google Scholar
PubMed
Close
 PhD, MPH
,
Ayhan Ulusakarya From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.

Search for other papers by Ayhan Ulusakarya in
Current site
Google Scholar
PubMed
Close
 MD
,
Elisabet Ortiz-Tudela From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.
From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.

Search for other papers by Elisabet Ortiz-Tudela in
Current site
Google Scholar
PubMed
Close
 MSc
,
Lucile Capuron From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.
From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.

Search for other papers by Lucile Capuron in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Pasquale F. Innominato From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.
From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; APHP, Department of Oncology, Paul Brousse Hospital, Villejuif, France; Chronobiology Laboratory, Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain; INSERM UMRS776 “Biological Rhythms and Cancers,” Villejuif, France; Laboratory of Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Bordeaux, France; and University of Bordeaux, Bordeaux, France.

Search for other papers by Pasquale F. Innominato in
Current site
Google Scholar
PubMed
Close
 MD, PhD
Restricted access

Sleep disruption is prevalent in patients and survivors of breast cancer. Most patients undergoing chemotherapy will experience transient sleep disruption, and nearly 60% will have chronic sleep problems. Numerous factors contribute to sleep disruption in women diagnosed with breast cancer. Sleep disruption is a consequence of several biological alterations, including circadian disruption and immune and metabolic deregulations. These systems also play significant roles in the control and progression of breast cancer. Sleep disruption is associated with many side effects and psychiatric and medical comorbidities. This article discusses the relationship between stress and posttraumatic stress disorder, depression and fatigue, and how sleep disturbance might be the cause or consequence of these disorders. Current evidence for management of sleep disturbance in breast cancer and high chronic use of hypnotic medication in this population is also discussed. Finally, the differences in management of sleep disturbance during acute cancer care and during the survivorship phase are discussed. More research is needed on accurate and timely assessment of sleep disturbance associated with breast cancer, and additional tailored approaches for the management of sleep problems in breast cancer should be developed.

Correspondence: Oxana Palesh, PhD, MPH, 401 Quarry Road, Office 2318, Stanford, CA 94305-5718. E-mail: opalesh@stanford.edu
  • Collapse
  • Expand
  • 1.

    Palesh OG, Roscoe JA, Mustian KM et al.. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 2010;28:292298.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Savard J, Ivers H, Villa J et al.. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol 2011;29:35803586.

  • 3.

    Palesh OG, Collie K, Batiuchok D et al.. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007;75:3744.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Koopman C, Nouriani B, Erickson V et al.. Sleep disturbances in women with metastatic breast cancer. Breast J 2002;8:362370.

  • 5.

    Berger AM, Wielgus K, Hertzog M et al.. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 2010;18:105114.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Savard J, Liu L, Natarajan L et al.. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep 2009;32:11551160.

  • 7.

    Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:9941000.

  • 8.

    Kondratova AA, Kondratov RV. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 2012;13:325335.

  • 9.

    Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev 2010;62:967978.

  • 10.

    Cochrane A, Robertson IH, Coogan AN. Association between circadian rhythms, sleep and cognitive impairment in healthy older adults: an actigraphic study. J Neural Transm 2012;119:12331239.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Innominato PF, Levi FA, Bjarnason GA. Chronotherapy and the molecular clock: clinical implications in oncology. Adv Drug Deliv Rev 2010;62:9791001.

  • 12.

    Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001;933:222234.

  • 13.

    Krueger JM, Takahashi S, Kapas L et al.. Cytokines in sleep regulation. Adv Neuroimmunol 1995;5:171188.

  • 14.

    Opp MR, Born J, Irwin MR. Sleep and the immune system. In: Ader R, ed. Psychoneuroimmunology. Vol. 4 New York, NY: Academic Press; 2007:579618.

  • 15.

    Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011;130:226238.

  • 16.

    Rich T, Innominato PF, Boerner J et al.. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005;11:17571764.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Mills PJ, Parker B, Dimsdale JE et al.. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 2005;69:8596.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Schubert C, Hong S, Natarajan L et al.. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007;21:413427.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Opp MR. Cytokines and sleep. Sleep Med Rev 2005;9:355364.

  • 20.

    Liu L, Mills PJ, Rissling M et al.. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 2012;26:706713.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:17851788.

  • 22.

    Panossian LA, Veasey SC. Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea—a review. Sleep 2012;35:605615.

  • 23.

    Lucassen EA, Rother KI, Cizza G. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci 2012;1264:110134.

  • 24.

    Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer 2012;118(8 Suppl):22612269.

  • 25.

    Gerber LH, Stout N, McGarvey C et al.. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer 2011;19:15811591.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10:541553.

  • 27.

    Morin C. Insomnia: Psychological Assessment and Management. New York: Guilford Press; 1993.

  • 28.

    Hunter MS, Grunfeld EA, Mittal S et al.. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 2004;13:769778.

  • 29.

    Carpenter JS, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:E1625.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Kravitz HM, Ganz PA, Bromberger J et al.. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:1928.

  • 31.

    Colagiuri B, Christensen S, Jensen AB et al.. Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manage 2011;42:710720.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Akechi T, Okuyama T, Akizuki N et al.. Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology 2007;16:888894.

  • 33.

    Lorizio W, Wu AH, Beattie MS et al.. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat 2012;132:11071118.

  • 34.

    Savard J, Ivers H. The initiation of chemotherapy, but not radiation therapy, coincides with increased insomnia. Psychooncology 2012;21:3738.

  • 35.

    Palesh O, Peppone L, Innominato PF et al.. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep 2012;4:151162.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Palesh O, Koopman C. Breast cancer: post-traumatic stress disorder-prevalent and persistent. Nat Rev Clin Oncol 2013;10:252254.

  • 37.

    Vin-Raviv N, Hillyer GC, Hershman DL et al.. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst 2013;105:563572.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Grandner MA, Hale L, Jackson N et al.. Perceived racial discrimination as an independent predictor of sleep disturbance and daytime fatigue. Behav Sleep Med 2012;10:235249.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Thomas KS, Bardwell WA, Ancoli-Israel S, Dimsdale JE. The toll of ethnic discrimination on sleep architecture and fatigue. Health Psychol 2006;25:635642.

  • 40.

    Tomfohr L, Pung MA, Edwards KM, Dimsdale JE. Racial differences in sleep architecture: the role of ethnic discrimination. Biol Psychol 2012;89:3438.

  • 41.

    Otte JL, Carpenter JS, Russell KM et al.. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage 2010;39:535547.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Beatty DL, Hall MH, Kamarck TA et al.. Unfair treatment is associated with poor sleep in African American and Caucasian adults: Pittsburgh SleepSCORE project. Health Psychol 2011;30:351359.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Palesh OG, Mustian KM, Peppone LJ et al.. Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Med 2012;13:11841190.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44.

    Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 2008;26:768777.

  • 45.

    Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008;110:917.

  • 46.

    Vargas S, Wohlgemuth WK, Antoni MH et al.. Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psychooncology 2010;19:669673.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Ancoli-Israel S, Liu L, Marler MR et al.. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006;14:201209.

  • 48.

    Berger AM, Farr LA, Kuhn BR et al.. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 2007;33:398409.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Phillips KM, Jim HS, Donovan KA et al.. Characteristics and correlates of sleep disturbances in cancer patients. Support Care Cancer 2012;20:357365.

  • 50.

    Berger AM, Kuhn BR, Farr LA et al.. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol 2009;27:60336040.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Fiorentino L, Ancoli-Israel S. Sleep dysfunction in patients with cancer. Curr Treat Options Neurol 2007;9:337346.

  • 52.

    Parker KP, Bliwise DL, Ribeiro M et al.. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol 2008;26:24642472.

  • 53.

    Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993;11:9971004.

  • 54.

    Roscoe JA, Perlis ML, Pigeon WR et al.. Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy. J Psychosom Res 2011;71:423428.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55.

    Palesh O, Aldridge-Gerry A, Zeitzer J et al.. Actigraphy measured sleep disruption as a predictor of survival among women with advanced breast cancer [abstract]. J Clin Oncol 2013;31(Suppl):Abstract 9532.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56.

    Morgenthaler T, Kramer M, Alessi C et al.. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 2006;29:14151419.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 2005;23:60836096.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    Espie CA, Fleming L, Cassidy J et al.. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008;26:46514658.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Berger AM, Kuhn BR, Farr LA et al.. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology 2009;18:634646.

  • 60.

    Barsevick A, Beck SL, Dudley WN et al.. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage 2010;40:200216.

  • 61.

    Costantini C, Ale-Ali A, Helsten T. Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer. J Palliat Med 2011;14:563566.

  • 62.

    Casault L, Savard J, Ivers H et al.. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support Care Cancer 2012;20:12031210.

  • 63.

    Riechelmann RP, Tannock IF, Wang L et al.. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007;99:592600.

  • 64.

    Jacobsen PB, Massie MJ, Kinne DW, Holland JC. Hypnotic efficacy and safety of triazolam administered during the postoperative period. Gen Hosp Psychiatry 1994;16:419425.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Hansen MV, Madsen MT, Hageman I et al.. The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial. BMJ Open 2012;2:e000647.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Mock V, Dow KH, Meares CJ et al.. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:9911000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Van Someren EJ, Lijzenga C, Mirmiran M, Swaab DF. Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms 1997;12:146156.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68.

    Norman JF, Von Essen SG, Fuchs RH, McElligott M. Exercise training effect on obstructive sleep apnea syndrome. Sleep Res Online 2000;3:121129.

  • 69.

    Tanaka H, Taira K, Arakawa M et al.. Effects of short nap and exercise on elderly people having difficulty in sleeping. Psychiatry Clin Neurosci 2001;55:173174.

  • 70.

    King AC, Oman RF, Brassington GS et al.. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA 1997;277:3237.

  • 71.

    Tworoger SS, Yasui Y, Vitiello MV et al.. Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep 2003;26:830836.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72.

    Humpel N, Iverson DC. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur J Cancer Care (Engl) 2010;19:761768.

  • 73.

    Young-McCaughan S, Mays MZ, Arzola SM et al.. Research and commentary: change in exercise tolerance, activity and sleep patterns, and quality of life in patients with cancer participating in a structured exercise program. Oncol Nurs Forum 2003;30:441454; discussion 441-454.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74.

    Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 2001;10:245255.

  • 75.

    Neikrug AB, Rissling M, Trofimenko V et al.. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med 2012;10:202216.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76.

    Mustian M, Sprod L, Peppone L et al.. Effect of YOCAS yoga on circadian rhythm, anxiety, and mood: a URCC CCOP randomized, controlled clinical trial among 410 cancer survivors [abstract]. J Clin Oncol 2011;29(Suppl):Abstract 9034.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77.

    Mustian KM, Sprod LK, Janelsins M et al.. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 2013;10;31:32333241.

  • 78.

    Denlinger CS, Carlson RW, Are M et al.. NCCN Clinical Practice Guidelines in Oncology: Survivorship. Version 1, 2013. Available at: NCCN.org. Accessed November 14, 2013.

  • 79.

    Ortiz-Tudela E, Martinez-Nicolas A, Campos M et al.. A new integrated variable based on thermometry, actimetry and body position (TAP) to evaluate circadian system status in humans. PLoS Comput Biol 2010;6:e1000996.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 5242 1600 219
PDF Downloads 2305 682 76
EPUB Downloads 0 0 0